US › Financial Services

Tekla Life Sciences Investors (HQL)

US · Financial Services · Asset Management

$19.70+2.23%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$48.1M
Revenue YoY
+2227.6%
Net profit
$65.3M
Profit YoY
+30.0%
EPS
$4.38
EPS estimate
$0.00
Net margin
135.9%

Key statistics

Market cap
$580.8M
P/E
2.9
Forward P/E
0.0
P/B
1.04
Book value
$18.44
EPS (TTM)
$6.64
Dividend yield
9.83%
52-week high
$21.32
52-week low
$11.51
50-day MA
$18.65
200-day MA
$17.42
Beta
0.71

Shareholding

Insiders
0.00%
Institutions
27.78%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Tekla Life Sciences Investors — free to start.

Google PlayApp Store

Other Financial Services companies

Berkshire Hathaway IncBerkshire Hathaway IncJPMorgan Chase & CoVisa Inc. Class AMastercard IncBank of America CorpHSBC Holdings PLC ADRMorgan StanleyGoldman Sachs Group IncRoyal Bank of CanadaWells Fargo & CompanyMitsubishi UFJ Financial Group Inc ADR

Data updated 2026-08-05.